119 related articles for article (PubMed ID: 33692858)
1. Four potential microRNAs affect the progression of pancreatic ductal adenocarcinoma by targeting MET via the PI3K/AKT signaling pathway.
Yao LC; Jiang XH; Yan SS; Wang W; Wu L; Zhai LL; Xiang F; Ji T; Ye L; Tang ZG
Oncol Lett; 2021 Apr; 21(4):326. PubMed ID: 33692858
[TBL] [Abstract][Full Text] [Related]
2. Construction of a prognostic prediction system for pancreatic ductal adenocarcinoma to investigate the key prognostic genes.
Zheng B; Peng J; Mollayup A; Bakri A; Guo L; Zheng J; Xu H
Mol Med Rep; 2018 Jan; 17(1):216-224. PubMed ID: 29115420
[TBL] [Abstract][Full Text] [Related]
3. NUSAP1 promotes pancreatic ductal adenocarcinoma progression by drives the epithelial-mesenchymal transition and reduces AMPK phosphorylation.
Liu Y; Tang R; Meng QC; Shi S; Xu J; Yu XJ; Zhang B; Wang W
BMC Cancer; 2024 Jan; 24(1):87. PubMed ID: 38229038
[TBL] [Abstract][Full Text] [Related]
4. Identification of Prognostic Biomarkers by Combined mRNA and miRNA Expression Microarray Analysis in Pancreatic Cancer.
Liu B; Yang H; Taher L; Denz A; Grützmann R; Pilarsky C; Weber GF
Transl Oncol; 2018 Jun; 11(3):700-714. PubMed ID: 29631214
[TBL] [Abstract][Full Text] [Related]
5. CTSK and PLAU as Prognostic Biomarker and Related to Immune Infiltration in Pancreatic Cancer: Evidence from Bioinformatics Analysis and qPCR.
Ding Y; Li Z; Wang H; Wang Q; Jiang H; Yu Z; Xu M
Int J Genomics; 2023; 2023():3914687. PubMed ID: 38077303
[TBL] [Abstract][Full Text] [Related]
6. AHNAK2 Promotes the Progression of Pancreatic Ductal Adenocarcinoma by Maintaining the Stability of c-MET.
Chen Z; Miao P; Lin H; Lu Y
Cancer Manag Res; 2024; 16():431-444. PubMed ID: 38751848
[TBL] [Abstract][Full Text] [Related]
7. Dysregulated miRNAs modulate tumor microenvironment associated signaling networks in pancreatic ductal adenocarcinoma.
Liu T; Chen Z; Chen W; Evans R; Xu J; Reeves ME; de Vera ME; Wang C
Precis Clin Med; 2023 Mar; 6(1):pbad004. PubMed ID: 37007745
[TBL] [Abstract][Full Text] [Related]
8. Potential Use of Anti-Cancer Drugs for Treatment of Preeclampsia by Targeting the miRNA-IGF1R-PI3K-AKT Axis.
Li J; Hou L; Zhao R; Zou L
Evid Based Complement Alternat Med; 2022; 2022():3883082. PubMed ID: 36045666
[TBL] [Abstract][Full Text] [Related]
9. GSK2126458 has the potential to inhibit the proliferation of pancreatic cancer uncovered by bioinformatics analysis and pharmacological experiments.
Feng Y; Jiang Y; Hao F
J Transl Med; 2021 Aug; 19(1):373. PubMed ID: 34461940
[TBL] [Abstract][Full Text] [Related]
10. Solute carrier family 16 member 1 as a potential prognostic factor for pancreatic ductal adenocarcinoma and its influence on tumor immunity.
Wang M; Liu L; Li X; Jiang W; Xiao J; Hao Q; Wang J; Reddy AV; Talbot A; Ikuta S; Tian D; Ren L
J Gastrointest Oncol; 2024 Apr; 15(2):730-746. PubMed ID: 38756638
[TBL] [Abstract][Full Text] [Related]
11. SPDEF drives pancreatic adenocarcinoma progression via transcriptional upregulation of S100A16 and activation of the PI3K/AKT signaling pathway.
Jiang H; Xue Z; Zhao L; Wang B; Wang C; Song H; Sun J
Biomol Biomed; 2024 Mar; ():. PubMed ID: 38520747
[TBL] [Abstract][Full Text] [Related]
12. Endogenous Pancreatic Cancer Cell PD-1 Activates MET and Induces Epithelial-Mesenchymal Transition to Promote Cancer Progression.
Harper MM; Lin M; Qasem SA; Patel RA; Cavnar MJ; Pandalai PK; Gao M; Kim J
Cancers (Basel); 2022 Jun; 14(13):. PubMed ID: 35804822
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA co-expression networks exhibit increased complexity in pancreatic ductal compared to Vater's papilla adenocarcinoma.
Mazza T; Copetti M; Capocefalo D; Fusilli C; Biagini T; Carella M; De Bonis A; Mastrodonato N; Piepoli A; Pazienza V; Maiello E; di Mola FF; di Sebastiano P; Andriulli A; Tavano F
Oncotarget; 2017 Dec; 8(62):105320-105339. PubMed ID: 29285254
[TBL] [Abstract][Full Text] [Related]
14. Investigating the influence of taurochenodeoxycholic acid (TCDCA) on pancreatic cancer cell behavior: An RNA sequencing approach.
Gál E; Parvaneh S; Miklós V; Hegyi P; Kemény L; Veréb Z; Venglovecz V
J Biotechnol; 2024 May; 391():20-32. PubMed ID: 38815810
[TBL] [Abstract][Full Text] [Related]
15. Kinase activities in pancreatic ductal adenocarcinoma with prognostic and therapeutic avenues.
Vallés-Martí A; de Goeij-de Haas RR; Henneman AA; Piersma SR; Pham TV; Knol JC; Verheij J; Dijk F; Halfwerk H; Giovannetti E; Jiménez CR; Bijlsma MF
Mol Oncol; 2024 Apr; ():. PubMed ID: 38650175
[TBL] [Abstract][Full Text] [Related]
16. Infection with COVID-19 promotes the progression of pancreatic cancer through the PI3K-AKT signaling pathway.
Zhang X; Chen B; Liu K; Ma Y; Liu Y; Zhou H; Wei P
Discov Oncol; 2023 Dec; 14(1):225. PubMed ID: 38063927
[TBL] [Abstract][Full Text] [Related]
17. Network dynamics and therapeutic aspects of mRNA and protein markers with the recurrence sites of pancreatic cancer.
Acharjee A; Okyere D; Nath D; Nagar S; Gkoutos GV
Heliyon; 2024 May; 10(10):e31437. PubMed ID: 38803850
[TBL] [Abstract][Full Text] [Related]
18. Prioritizing cervical cancer candidate genes using chaos game and fractal-based time series approach.
Mallikarjuna T; Thummadi NB; Vindal V; Manimaran P
Theory Biosci; 2024 May; ():. PubMed ID: 38807013
[TBL] [Abstract][Full Text] [Related]
19. Crosstalk between miRNAs and signaling pathways involved in pancreatic cancer and pancreatic ductal adenocarcinoma.
Lotfi Z; Najjary S; Lotfi F; Amini M; Baghbanzadeh A; Rashid DJ; Asl ER; Baradaran B; Mokhtarzadeh A
Eur J Pharmacol; 2021 Jun; 901():174006. PubMed ID: 33711308
[TBL] [Abstract][Full Text] [Related]
20. Upregulated MicroRNA-483-3p is an Early Event in Pancreatic Ductal Adenocarcinoma (PDAC) and as a Powerful Liquid Biopsy Biomarker in PDAC.
Shao H; Zhang Y; Yan J; Ban X; Fan X; Chang X; Lu Z; Wu Y; Zong L; Mo S; Yu S; Chen J
Onco Targets Ther; 2021; 14():2163-2175. PubMed ID: 33790579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
